Search

Your search keyword '"Fujii Kentaro"' showing total 564 results

Search Constraints

Start Over You searched for: Author "Fujii Kentaro" Remove constraint Author: "Fujii Kentaro"
564 results on '"Fujii Kentaro"'

Search Results

2. Clinical relevance of proteinuria selectivity index and fractional excretion of sodium in patients with nephrotic syndrome

4. Periportal macrophages protect against commensal-driven liver inflammation

11. The utility of DNA methylation analysis in elderly patients with pilocytic astrocytoma morphology

15. New Anti‐Angiogenic Therapy for Glioblastoma With the Anti‐Depressant Sertraline.

17. Nature of the physicochemical process in water photolysis uncovered by a computer simulation.

18. Observation of the Liquid–Liquid Phase Separation of FUS‐LC Using Vacuum‐Ultraviolet Circular Dichroism Spectroscopy.

19. Ultrafast fragmentation of highly-excited doubly-ionized deoxyribose: role of the liquid water environment.

26. Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity

27. A Case of High-Grade Glioma in an Eloquent Area Treated with Awake Craniotomy in an 85-year-old Patient

28. Utility of Comprehensive Genomic Profiling for Precise Diagnosis of Pediatric-Type Diffuse High-Grade Glioma

29. Combined simultaneous endoscopic endonasal and transcranial surgery using high‐definition three‐dimensional exoscope for malignant tumors of the anterior skull base.

32. CTNI-72. PHASE II TRIAL OF PATHOLOGY-BASED THREE-GROUP TREATMENT STRATIFICATION FOR PATIENTS WITH CNS GERM CELL TUMORS: A LONG-TERM FOLLOW-UP STUDY

36. Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan

37. OMICS AND PROGNSTIC MARKERS

44. Publisher Correction: Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity

45. Genomic Profiling of a Case of Glioneuronal Tumor with Neuropil-like Islands

46. Data from Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling Pathways

47. Supplementary Figure 3 from Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling Pathways

48. Supplementary Figure 1 from Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling Pathways

49. Supplementary Figure 2 from Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling Pathways

50. Multidrug chemotherapy, whole-brain radiation and cytarabine therapy for primary central nervous system lymphoma in elderly patients with dose modification based on geriatric assessment: study protocol for a phase II, multicentre, non-randomised study

Catalog

Books, media, physical & digital resources